156 related articles for article (PubMed ID: 30015912)
41. miR-103 Promotes Proliferation and Metastasis by Targeting KLF4 in Gastric Cancer.
Zheng J; Liu Y; Qiao Y; Zhang L; Lu S
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28445396
[TBL] [Abstract][Full Text] [Related]
42. HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE/NF-κB signaling pathway.
Xie Y; Yu N; Chen Y; Zhang K; Ma HY; Di Q
Mol Med Rep; 2017 Aug; 16(2):1691-1700. PubMed ID: 28627626
[TBL] [Abstract][Full Text] [Related]
43. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
Chen SY; Teng SC; Cheng TH; Wu KJ
Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
[TBL] [Abstract][Full Text] [Related]
44. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
Cho KH; Yu SL; Cho DY; Park CG; Lee HY
BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
[TBL] [Abstract][Full Text] [Related]
45. Apigenin inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma.
Qin Y; Zhao D; Zhou HG; Wang XH; Zhong WL; Chen S; Gu WG; Wang W; Zhang CH; Liu YR; Liu HJ; Zhang Q; Guo YQ; Sun T; Yang C
Oncotarget; 2016 Jul; 7(27):41421-41431. PubMed ID: 27203387
[TBL] [Abstract][Full Text] [Related]
46. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
47. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
[TBL] [Abstract][Full Text] [Related]
48. The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer.
Yu WW; Jiang H; Zhang CT; Peng Y
Oncotarget; 2017 Jun; 8(24):39280-39295. PubMed ID: 28424413
[TBL] [Abstract][Full Text] [Related]
49. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
50. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
51. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
52. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
[TBL] [Abstract][Full Text] [Related]
53. RAGE Up-Regulation Differently Affects Cell Proliferation and Migration in Pancreatic Cancer Cells.
Swami P; Thiyagarajan S; Vidger A; Indurthi VSK; Vetter SW; Leclerc E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086527
[TBL] [Abstract][Full Text] [Related]
54. The receptor for advanced glycation endproducts (RAGE) decreases survival of tumor-bearing mice by enhancing the generation of lung metastasis-associated myeloid-derived suppressor cells.
Wuren T; Huecksteadt T; Beck E; Warren K; Hoidal J; Ostrand-Rosenberg S; Sanders K
Cell Immunol; 2021 Jul; 365():104379. PubMed ID: 34038758
[TBL] [Abstract][Full Text] [Related]
55. RAGE/SNAIL1 signaling drives epithelial-mesenchymal plasticity in metastatic triple-negative breast cancer.
Pujals M; Mayans C; Bellio C; Méndez O; Greco E; Fasani R; Alemany-Chavarria M; Zamora E; Padilla L; Mitjans F; Nuciforo P; Canals F; Nonell L; Abad M; Saura C; Tabernero J; Villanueva J
Oncogene; 2023 Aug; 42(35):2610-2628. PubMed ID: 37468678
[TBL] [Abstract][Full Text] [Related]
56. Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer.
Healey GD; Pan-Castillo B; Garcia-Parra J; Davies J; Roberts S; Jones E; Dhar K; Nandanan S; Tofazzal N; Piggott L; Clarkson R; Seaton G; Frostell A; Fagge T; McKee C; Margarit L; Conlan RS; Gonzalez D
J Immunother Cancer; 2019 Oct; 7(1):280. PubMed ID: 31665084
[TBL] [Abstract][Full Text] [Related]
57. RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer.
Chen MC; Chen KC; Chang GC; Lin H; Wu CC; Kao WH; Teng CJ; Hsu SL; Yang TY
Cell Death Dis; 2020 Apr; 11(4):265. PubMed ID: 32327633
[TBL] [Abstract][Full Text] [Related]
58. Diaphanous-1 affects the nanoscale clustering and lateral diffusion of receptor for advanced glycation endproducts (RAGE).
Zhu Q; Smith EA
Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):43-49. PubMed ID: 30401627
[TBL] [Abstract][Full Text] [Related]
59. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.
Mercado-Pimentel ME; Onyeagucha BC; Li Q; Pimentel AC; Jandova J; Nelson MA
FEBS Lett; 2015 Aug; 589(18):2388-93. PubMed ID: 26193421
[TBL] [Abstract][Full Text] [Related]
60. The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.
Talia M; Cirillo F; Spinelli A; Zicarelli A; Scordamaglia D; Muglia L; De Rosis S; Rigiracciolo DC; Filippelli G; Perrotta ID; Davoli M; De Rosa R; Macirella R; Brunelli E; Miglietta AM; Nardo B; Tosoni D; Pece S; De Francesco EM; Belfiore A; Maggiolini M; Lappano R
J Exp Clin Cancer Res; 2023 Jul; 42(1):164. PubMed ID: 37434266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
